Cost-effectiveness of endovascular treatment for acute ischemic stroke in China: evidence from Shandong Peninsula

Health Economics Review

Table 2 The results of cost-effectiveness

Time horizon	Strategy	Cost	QALYs	Cost- effectiveness ratio	ICER
3 months	EVT alone	71329.86	0.15	461844.71	9288851.75
3 months	EVT + IVT	108463.60	0.16	684558.18	9288851.75
1 year	EVT alone	82358.75	0.74	111565.82	2004182.77
1 year	EVT + IVT	119568.88	0.76	157998.14	2004182.77
The life horizon	EVT alone	271740.90	2.82	96234.35	696399.30
The life horizon	EVT + IVT	359160.29	2.95	121779.32	696399.30

Note: ICER, incremental cost-effectiveness ratio; QALYs, quality-adjusted life-years

ISSN: 2191-1991